Severe Primary Raynaud’s Disease Treated with Rituximab
Raynaud’s phenomenon refers to reversible spasms of the peripheral arterioles that can be primary Raynaud’s phenomenon (PRP) or secondary Raynaud’s phenomenon (SRP) to underlying connective tissue disease, both of which are characterized by a triphasic color response triggered by cold exposure or st...
Saved in:
Main Authors: | Mohammed Shabrawishi, Abdurahman Albeity, Hani Almoallim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2016/2053804 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
by: Neveen Awad, et al.
Published: (2016-01-01) -
Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies
by: Michael Doherty, et al.
Published: (2015-03-01) -
Extensive calcinosis in a patient with raynaud's phenomenon and anti-ku antibody positivity
by: Kunal Chandwar, et al.
Published: (2022-01-01) -
Lymphomatoid Granulomatosis Treated Successfully with Rituximab in a Renal Transplant Patient
by: Cindy Castrale, et al.
Published: (2011-01-01) -
Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab
by: Jacob P. Smeltzer, et al.
Published: (2014-01-01)